SG34210A1 - Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract - Google Patents

Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract

Info

Publication number
SG34210A1
SG34210A1 SG1995000074A SG1995000074A SG34210A1 SG 34210 A1 SG34210 A1 SG 34210A1 SG 1995000074 A SG1995000074 A SG 1995000074A SG 1995000074 A SG1995000074 A SG 1995000074A SG 34210 A1 SG34210 A1 SG 34210A1
Authority
SG
Singapore
Prior art keywords
active ingredient
medicinal active
targeted site
pharmaceutical preparation
intestinal tract
Prior art date
Application number
SG1995000074A
Other languages
English (en)
Inventor
Yoshiyuki Hirakawa
Hiroyuki Yoshino
Eiji Fukui
Tami Hanamori
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12593695&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG34210(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SG34210A1 publication Critical patent/SG34210A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1995000074A 1994-03-11 1995-03-08 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract SG34210A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6040911A JP2917799B2 (ja) 1994-03-11 1994-03-11 消化管内適所放出型製剤

Publications (1)

Publication Number Publication Date
SG34210A1 true SG34210A1 (en) 1996-12-06

Family

ID=12593695

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995000074A SG34210A1 (en) 1994-03-11 1995-03-08 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract

Country Status (14)

Country Link
US (1) US5725880A (de)
EP (1) EP0671168B1 (de)
JP (1) JP2917799B2 (de)
KR (1) KR100305234B1 (de)
CN (1) CN1116523A (de)
AT (1) ATE193439T1 (de)
CA (1) CA2144094C (de)
DE (1) DE69517218T2 (de)
DK (1) DK0671168T3 (de)
ES (1) ES2148365T3 (de)
GR (1) GR3033593T3 (de)
PT (1) PT671168E (de)
SG (1) SG34210A1 (de)
TW (1) TW422708B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2120354B1 (es) * 1996-02-12 1999-07-01 Univ Sevilla Dispositivo terapeutico para direccionar farmacos hacia el tramo del tracto gastrointestinal deseado en funcion de las caracteristicas fisicoquimicas del mismo.
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
KR100501022B1 (ko) 1998-07-28 2005-07-18 다나베 세이야꾸 가부시키가이샤 장내 적소 방출형 제제
CA2360655C (en) 1999-01-29 2007-03-20 Losan Pharma Gmbh Pharmaceutical compositions
FR2790387B1 (fr) * 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
WO2001054671A1 (fr) * 2000-01-27 2001-08-02 Tanabe Seiyaku Co., Ltd. Preparation a liberation prolongee et son procede de fabrication
US6420473B1 (en) 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
WO2001058429A1 (en) * 2000-02-10 2001-08-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
IT1318625B1 (it) * 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
US20030072731A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing starch or dextrin
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
WO2004087109A1 (ja) * 2003-03-27 2004-10-14 Hisamitsu Pharmaceutical Co., Inc. 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
US20060024368A1 (en) * 2004-07-30 2006-02-02 Reza Fassihi Compressed composite delivery system for release-rate modulation of bioactives
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
JPWO2007010846A1 (ja) * 2005-07-15 2009-01-29 キッセイ薬品工業株式会社 胃内滞留製剤
AU2006274835B2 (en) 2005-07-29 2012-05-24 Abbott Laboratories Gmbh Processes for the manufacture of sterilized pancreatin powder
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
ATE457719T2 (de) 2005-08-15 2010-03-15 Solvay Pharm Gmbh Pharmazeutische zusammensetzungen mit kontrollierter freisetzung für säurelabile arzneimittel
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
EP2105133A1 (de) * 2007-01-15 2009-09-30 Kissei Pharmaceutical Co., Ltd. Herstellung schwebender intragastraler levodopa mit verzögerter freisetzung
WO2008132727A2 (en) * 2007-04-26 2008-11-06 Technion Research And Development Foundation Ltd Oral delivery of proteins and peptides
CN101707877B (zh) 2007-06-13 2013-01-09 杰伊·普拉夫达 诊断与治疗氧化过激类病症的材料和方法
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
MX2011003595A (es) 2008-10-03 2011-07-28 Falk Pharma Gmbh Composiciones y metodos para el tratamiento de enfermedades intestinales con mesalamina granulada.
EP2255794A1 (de) * 2009-05-29 2010-12-01 H e x a l Aktiengesellschaft Magensaftresistenter Überzug
JP5496616B2 (ja) * 2009-11-18 2014-05-21 フロイント産業株式会社 大腸ドラッグデリバリーシステム製剤
US10463699B2 (en) 2016-04-04 2019-11-05 Omeza LLC Fish oil topical composition
US10765635B2 (en) * 2018-02-06 2020-09-08 Nano Pharmaceutical Laboratories Llc Multiparticulate including pharmaceutical or probiotic active ingredients for delivery via a shelf stable liquid dosage form
AU2022307756A1 (en) * 2021-07-09 2024-02-22 Evonik Operations Gmbh Composition comprising a (meth)acrylate copolymer, an alkali or ammonium salt of a saturated aliphatic monocarboxylic acid and specific glidants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325365A (en) * 1963-04-02 1967-06-13 Ciba Geigy Corp Enteric composition for tablet compression coating
US3608030A (en) * 1969-05-21 1971-09-21 Howard Tint Method of preparing a tablet dosage-form for the immunization of the intestinal tract with live virus preparations
GB1456365A (en) * 1972-10-06 1976-11-24 Gist Brocades Nv Controlled release composition
CA1308357C (en) * 1987-01-28 1992-10-06 Tohru Chiba Method for the preparation of a coated solid medicament
JP2773959B2 (ja) * 1990-07-10 1998-07-09 信越化学工業株式会社 大腸内放出性固形製剤
US5162117A (en) * 1991-11-22 1992-11-10 Schering Corporation Controlled release flutamide composition

Also Published As

Publication number Publication date
DE69517218D1 (de) 2000-07-06
CA2144094C (en) 2004-01-27
US5725880A (en) 1998-03-10
GR3033593T3 (en) 2000-09-29
KR100305234B1 (ko) 2002-04-24
DK0671168T3 (da) 2000-08-07
ES2148365T3 (es) 2000-10-16
CN1116523A (zh) 1996-02-14
DE69517218T2 (de) 2000-11-30
CA2144094A1 (en) 1995-09-12
JPH07247222A (ja) 1995-09-26
EP0671168A1 (de) 1995-09-13
JP2917799B2 (ja) 1999-07-12
ATE193439T1 (de) 2000-06-15
KR950031046A (ko) 1995-12-18
TW422708B (en) 2001-02-21
EP0671168B1 (de) 2000-05-31
PT671168E (pt) 2000-09-29

Similar Documents

Publication Publication Date Title
GR3033593T3 (en) Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract.
MX9500885A (es) Preparacion farmaceutica para administracion oral.
ATE205705T1 (de) Arzneimittel zum wirkstoff - targetting in den dickdarm
WO1998056360A3 (en) Film-coated tablet for improved upper gastrointestinal tract safety
HU9302379D0 (en) Peroral medical preparatives with retarded releasing of active agents for treating intestinal diseases
ES2149250T3 (es) Dispositivo para la administracion de medicamentos con liberacion controlada.
IL140020A0 (en) Methods and devices for providing prolonged drug therapy
WO2007079082A3 (en) Gastric release pulse system for drug delivery
NO20003640L (no) Ny doseringsform
NZ237516A (en) Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release
NO940376L (no) Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet
CA2190148A1 (en) Oral liquid alendronate formulations
SG80553A1 (en) Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
RU2227033C2 (ru) Тауролидин и/или таурултам при лечении инфекционной язвенной болезни или инфекционного гастрита
WO1998026767A3 (en) Site-specific controlled release dosage formulation for mesalamine
CA2032475A1 (en) Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
EP0271151A3 (de) Azumolen-Dosisformen
JP2001514218A5 (de)
RU2001131112A (ru) Препаративная форма для введения в подвздошную кишку, включающая соединение, ингибирующее транспорт подвздошнокишечной желчной кислоты